多重原发性癌症与血液恶性瘤和生殖线倾向:一个病例系列
Jiwon Yun1, Dong Soon Lee2, Sungyoung Lee3
1Department of Laboratory Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Annals of laboratory medicine
|March 7, 2024
概括
多重原发性 (MP) 癌症与血液恶性瘤相结合是罕见的. 这项研究在40%的患者中发现了生殖系变异,这表明生殖系测试对于干细胞移植决策至关重要.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
背景情况:
- 多重原发性 (MP) 癌症在一个病人身上涉及多种不同的癌症.
- 瘤癌与血液性恶性瘤的同时发生很少.
- 了解这些复杂病例的遗传基础至关重要.
研究的目的:
- 研究MP癌症和血液恶性瘤患者的临床特征,细胞遗传学和生殖线/体质变异.
- 在这个患者队列中评估致病性生殖系变异的流行率.
- 为临床管理提供信息,特别是在干细胞移植方面.
主要方法:
- 五名患有MP癌症和血液恶性瘤的患者的回顾性分析.
- 对临床数据,细胞遗传特征以及生殖和体质遗传变异的全面评估.
- 对癌症倾向基因进行生殖系变异检测.
主要成果:
- 两名患者最初患有固体瘤,三名患者最初患有血液癌症.
- 所有的第二种原发性癌症都是血液性恶性瘤,不符合与治疗相关的骨髓瘤瘤标准.
- 五分之二的患者 (40%) 在癌症倾向基因中呈现了致病性或推定的生殖系变异.
结论:
- 在很大一部分患者中存在生殖系变异,这凸显了遗传评估的重要性.
- 在患有血性恶性瘤的MP癌症患者中,应考虑进行生殖系变异测试.
- 这在评估相关的供体干细胞移植候选人时尤为重要.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


